Related Experiment Video
Updated: Sep 18, 2025

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation
Published on: February 16, 2024
Macrophage Transcriptomic Alterations Driven by Alphavirus-Based Cancer Immunotherapy Vectors
Ksenija Korotkaja1, Darija Lapina1, Zhanna Rudevica1
1Cancer Gene Therapy Group, Latvian Biomedical Research and Study Centre, Ratsupites Str. 1 k. 1, Riga LV-1067, Latvia.
Viral immunotherapy vectors can reprogram tumor-associated macrophages (TAMs) to an anti-cancer M1 phenotype. Semliki Forest virus (SFV) vectors alter cancer cells, influencing macrophage reprogramming and potentially enhancing cancer therapy.
Area of Science:
- Immunology
- Virology
- Cancer Biology
Background:
- Tumor-associated macrophages (TAMs) often adopt a pro-tumorigenic M2 phenotype, hindering cancer therapy.
- Reprogramming TAMs to an anti-tumor M1 phenotype using viral immunotherapy vectors is a promising strategy.
- Understanding the mechanisms of macrophage reprogramming by viral vectors is crucial for effective cancer treatment.
Purpose of the Study:
- To investigate the transcriptomic alterations in macrophages induced by Semliki Forest virus (SFV) vectors.
- To determine how SFV-mediated gene delivery to cancer cells influences macrophage polarization.
- To explore the potential of alphavirus vectors for reprogramming macrophages towards an anti-cancer phenotype.
Main Methods:
- Murine mammary cancer cells were infected with SFV vectors carrying TNFα or IFNγ genes.
- Conditioned media from infected cancer cells were used to treat bone marrow-derived macrophages (BMDMs).
- Transcriptomic analysis (RNA sequencing) was performed on treated BMDMs to assess gene expression changes.
Main Results:
- SFV-infected cancer cells modulated cytokine profiles, reducing immunosuppression and increasing inflammation.
- Macrophage treatment with SFV-conditioned media upregulated genes related to antigen presentation, interferon response, and M1 polarization.
- SFV/IFNγ inhibited pro-tumorigenic pathways (angiogenesis, glycolysis, ECM remodeling) and increased cytotoxic T-lymphocyte attractants.
- SFV vectors upregulated PD-L1 (Cd274) expression on macrophages.
Conclusions:
- Alphavirus-mediated gene delivery to cancer cells can induce pro-inflammatory responses in macrophages, reprogramming them to an anti-cancer M1 phenotype.
- SFV vectors show potential for modulating the tumor microenvironment and enhancing anti-tumor immunity.
- Combining SFV/IFNγ with immune checkpoint inhibitors may improve therapeutic outcomes by counteracting virus-induced suppressive signals.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

